Related Experiment Video
Updated: Jul 25, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive fungal infections: a review of epidemiology and management options
D A Enoch1, H A Ludlam1, N M Brown1
1Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK.
Abstract:
Fungi are increasingly recognised as major pathogens in critically ill patients. Candida spp. and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most frequent filamentous fungi (moulds) isolated are Aspergillus spp., but Fusarium spp., Scedosporium spp., Penicillium spp., and Zygomycetes are increasingly seen. Several reasons have been proposed for the increase in invasive fungal infections, including the use of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics, and prosthetic devices and grafts, and more aggressive surgery. Patients with burns, neutropenia, HIV infection and pancreatitis are also predisposed to fungal infection. The epidemiology and clinical features of fungal infections are reviewed, together with antifungal agents currently or soon to be available.
Insights
Invasive fungal infections are rising in critically ill patients due to factors like immunosuppression and medical devices. This review covers fungal pathogens, risk factors, and available antifungal treatments.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Fungal infections are a growing concern in intensive care units.
- Candida spp. and Cryptococcus spp. are common yeasts, while Aspergillus spp. are frequent moulds.
- Emerging filamentous fungi include Fusarium spp., Scedosporium spp., Penicillium spp., and Zygomycetes.
Purpose of the Study:
- To review the epidemiology and clinical features of fungal infections in critically ill patients.
- To discuss factors contributing to the rise of invasive fungal infections.
- To outline currently available and emerging antifungal agents.
Main Methods:
- Literature review of fungal infections in critically ill patients.
- Analysis of epidemiological trends and predisposing factors.
- Overview of clinical manifestations and treatment options.
Main Results:
- Increased incidence of fungal infections in immunocompromised patients.
- Association of invasive fungal infections with specific medical interventions and conditions.
- Identification of key fungal pathogens and their clinical significance.
Conclusions:
- Critically ill patients face significant risk from invasive fungal infections.
- Understanding risk factors and pathogen spectrum is crucial for management.
- Antifungal therapy remains essential, with new agents offering future hope.
More Related Videos
06:02A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
Published on: November 6, 2020
06:53An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Endocarditis III: Medical Management
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Antifungal Agents